90
Views
31
CrossRef citations to date
0
Altmetric
Original Papers

Carnitine Increases Glucose Disposal in Humans

, MD, PhD (Math), , MD, PhD, FACN, , MD, FACS & , MD, PhD
Pages 289-295 | Received 01 Nov 1998, Accepted 01 Mar 1999, Published online: 07 Jun 2013

REFERENCES

  • Balogh D, Hackl JM, Legenstein E, Musil HE: Experiences with L-carnitine in the post-stress phase. Infusionsther Klin Ernahr 13: 204–208, 1986.
  • Bergman RN, Ider YZ, Bowden CR, Cobelli C: Quantitative estimation of insulin sensitivity. Am J Physiol 236: E667–E677, 1979.
  • Berliner JA, Frank HJL, Karasic D, Capdeville M: Lipoprotein-induced insulin resistance in aortic endothelium. Diabetes 33: 1038–1044, 1984.
  • Bowyer BA, Fleming CR, Haymond MW, Miles JM: L-carnitine: effect of intravenous administration on fuel homeostasis in normal subjects and home-parenteral-nutrition patients with low plasma carnitine concentrations. Am J Clin Nutr 49: 618–623, 1989.
  • Broderick TL, Quinney HA, Lopaschuk GD: Carnitine stimulation of glucose oxidation in the fatty acid perfused isolated working rat heart. J Biol Chem 267: 3758–3763, 1992.
  • Capaldo B, Napoli R, Di-Bonito P, Albano G, Sacca L: Carnitine improves peripheral glucose disposal in non-insulin-dependent diabetic patients. Diabetes Res Clin Pract 14: 191–195, 1991.
  • Caro JF, Sinha MK, Raju SM, Ittoop O, Pories WJ, Flickinger EG, Meelheim D, Dohm GL: Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. J Clin Invest 79: 1330–1337, 1987.
  • Cobelli C, Pacini G: Insulin secretion and hepatic extraction in humans by minimal modeling of C-peptide and insulin kinetics. Diabetes 37: 223–231, 1988.
  • De Gaetano A, Castagneto M, Mingrone G, Coleman WP, Sganga G, Tataranni PA, Gangeri G, Greco AV: PC-based differential model fitting as a support for clinical research. Int J Clin Monit Comput 11: 35–41, 1994.
  • Di Donato S, Garavaglia B, Rimoldi M, Carrara F: Clinical and biomedical phenotypes of carnitine deficiencies. In Ferrari R, Di Mauro S, Sherwood G (ed): “L-Carnitine and its Role in Medicine: From Function to Therapy.” London: Academic Press, 1992.
  • Felber JP, Vannotti A: Effect of fat infusion on glucose tolerance and insulin plasma levels. Med Exp 10: 153–156, 1964.
  • Ferrannini E: Theoretical basis of indirect calorimetry: a review. Metabolism 37: 287–301, 1988.
  • Ferrannini E, Buzzigoli G, Bevilacqua S, Boni C, Del Chiaro D, Oleggini M, Brandi L, Maccari F: Interaction of carnitine with insulin-stimulated glucose metabolism in humans. Am J Physiol 255: E946–E952, 1988.
  • Freidenberg GR, Henry RR, Klein HH, Reichart DR, Olefsky JM: Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects. J Clin Invest 79: 240–250, 1987.
  • Gomez F, Jecquier E, Chabot V, Buber V, Felber JP: Carbohydrate and lipid oxidation in normal human subjects: its influence on glucose tolerance and insulin response to glucose. Metabolism 21: 381–391, 1972.
  • Heller W, Musil HE, Gaebel G, Hempel V, Krug W, Kohn HJ: Effect of L-carnitine on post-stress metabolism in surgical patients. Infusionsther Klin Ernahr 13: 268–276, 1986.
  • Lysiak W, Lilly K, DiLisa F, Toth PP, Bieber LL: Quantitation of the effect of L-carnitine on the levels of acid-soluble short-chain acyl-CoA and CoASH in rat heart and liver mitochondria. J Biol Chem 263: 1151–1156, 1988.
  • Newsholme EA, Randle PJ, Manchester KL. Inhibition of the phosphofructokinase reaction in perfused rat heart by respiration of ketone bodies, fatty acids and pyruvate. Nature 193: 270–271, 1962.
  • Olefsky JM, Kolterman OG: Mechanisms of insulin resistance in obesity and in non-insulin-dependent (Type II) diabetes. Am J Med 70: 151–168, 1981.
  • Olefsky JM, Kolterman OG, Scarlett JA. Insulin action and resistance in obesity and non-insulin dependent Type II diabetes mellitus. Am J Physiol 243: E15–E30, 1982.
  • Paulson DJ, Schmidt MJ, Traxler JS, Ramacci MT, Shug AL: Improvement of myocardial function in diabetic rats after treatment with L-carnitine. Metabolism 33: 358–363, 1984.
  • Pieper GM, Salhany JM, Murray WJ, Wu ST, Eliot RS: Lipid-mediated impairment of normal energy metabolism in the isolated perfused diabetic rat heart studied by phosphorus-31 NMR and chemical extraction. Biochim Biophys Acta 803: 229–240, 1984.
  • Press WH, Flannery BP, Teukolsky SA, Vetterling WT: “Numerical recipes in C. The art of scientific computing.” New York: Cambridge University Press, 1988.
  • Randle PJ, Hales CN, Garland PB, Newsholme EA: The glucose-fatty acid cycle: its role in insulin sensitivity and metabolic disturbances of diabetes mellitus. Lancet 1: 785–789, 1963.
  • Rodrigues B, Xiang H, McNeill JH: Effect of L-carnitine treatment on lipid metabolism and cardiac performance in chronically diabetic rats. Diabetes 37: 1358–1364, 1988.
  • Toffolo G, Bergman RN, Finegood DT, Bowden CR, Cobelli C: Quantitative estimation of beta cell sensitivity to glucose in the intact organism: a minimal model of insulin kinetics in the dog. Diabetes 29: 979–990, 1980.
  • Wyss V, Ganzit GP, Rienzi A: Effects of L-carnitine administration on VO2max and the aerobic-anaerobic threshold in normoxia and acute hypoxia. Eur J Appl Physiol 60: 1–6, 1990.
  • Yamada H, Hironaka Y, Hama T: Effects of levocarnitine chloride, a new mitochondrial function reactivating agent, on fatty acid and glucose oxidation under hypoxic condition in homogenates from rat heart. Yakugaku Zasshi 110: 225–234, 1990.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.